Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymph Nodes | 9 | 2025 | 554 | 4.800 |
Why?
|
| Lab-On-A-Chip Devices | 7 | 2025 | 25 | 3.240 |
Why?
|
| Microfluidics | 9 | 2022 | 57 | 2.050 |
Why?
|
| Printing, Three-Dimensional | 3 | 2025 | 50 | 1.730 |
Why?
|
| B-Lymphocytes | 5 | 2024 | 760 | 1.250 |
Why?
|
| Mice, Inbred C57BL | 9 | 2025 | 3490 | 1.090 |
Why?
|
| Hydrogels | 2 | 2024 | 91 | 0.990 |
Why?
|
| Tissue Survival | 3 | 2020 | 13 | 0.960 |
Why?
|
| Antibodies | 2 | 2019 | 356 | 0.890 |
Why?
|
| Vaccination | 2 | 2024 | 311 | 0.880 |
Why?
|
| Interferon-gamma | 2 | 2024 | 462 | 0.870 |
Why?
|
| Mice | 17 | 2025 | 12536 | 0.870 |
Why?
|
| Chemokine CXCL9 | 1 | 2024 | 8 | 0.870 |
Why?
|
| Poly I-C | 1 | 2024 | 19 | 0.870 |
Why?
|
| Lymphocytes | 2 | 2023 | 465 | 0.820 |
Why?
|
| Xylenes | 1 | 2023 | 4 | 0.810 |
Why?
|
| Light | 1 | 2024 | 297 | 0.810 |
Why?
|
| Interferon Type I | 1 | 2024 | 171 | 0.790 |
Why?
|
| Oxygen Consumption | 1 | 2024 | 253 | 0.790 |
Why?
|
| Animals | 22 | 2025 | 28887 | 0.770 |
Why?
|
| Tissue Engineering | 2 | 2022 | 202 | 0.750 |
Why?
|
| Polymers | 1 | 2023 | 220 | 0.720 |
Why?
|
| CD3 Complex | 2 | 2019 | 136 | 0.710 |
Why?
|
| Digitonin | 1 | 2020 | 10 | 0.680 |
Why?
|
| Detergents | 1 | 2020 | 33 | 0.680 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2020 | 8 | 0.670 |
Why?
|
| Boron Compounds | 1 | 2020 | 20 | 0.640 |
Why?
|
| Microfluidic Analytical Techniques | 3 | 2017 | 46 | 0.630 |
Why?
|
| Polyesters | 1 | 2020 | 44 | 0.630 |
Why?
|
| In Vitro Techniques | 2 | 2021 | 1008 | 0.600 |
Why?
|
| Th1 Cells | 2 | 2024 | 172 | 0.600 |
Why?
|
| Pepsin A | 1 | 2019 | 5 | 0.600 |
Why?
|
| Spleen | 1 | 2020 | 420 | 0.590 |
Why?
|
| Leukocyte Common Antigens | 1 | 2018 | 51 | 0.580 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2018 | 96 | 0.570 |
Why?
|
| Frozen Sections | 1 | 2018 | 50 | 0.570 |
Why?
|
| Fluorescent Dyes | 1 | 2020 | 262 | 0.570 |
Why?
|
| Lectins, C-Type | 1 | 2018 | 89 | 0.560 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2018 | 326 | 0.550 |
Why?
|
| Cytokines | 3 | 2020 | 871 | 0.550 |
Why?
|
| Nonlinear Dynamics | 2 | 2017 | 74 | 0.530 |
Why?
|
| Glucose | 1 | 2020 | 701 | 0.530 |
Why?
|
| Optical Imaging | 1 | 2017 | 51 | 0.520 |
Why?
|
| Equipment Design | 4 | 2025 | 427 | 0.520 |
Why?
|
| Antigens, CD | 1 | 2018 | 480 | 0.500 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 102 | 0.500 |
Why?
|
| Osteoporosis | 1 | 2017 | 131 | 0.470 |
Why?
|
| Diffusion | 4 | 2017 | 95 | 0.470 |
Why?
|
| Signal Transduction | 2 | 2024 | 3581 | 0.460 |
Why?
|
| Multiple Sclerosis | 1 | 2017 | 263 | 0.440 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 322 | 0.430 |
Why?
|
| Blood Coagulation | 3 | 2009 | 90 | 0.420 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2014 | 96 | 0.410 |
Why?
|
| Heart-Assist Devices | 1 | 2022 | 898 | 0.410 |
Why?
|
| Liver | 1 | 2018 | 1231 | 0.400 |
Why?
|
| Th2 Cells | 1 | 2014 | 151 | 0.400 |
Why?
|
| Gelatin | 2 | 2024 | 27 | 0.380 |
Why?
|
| Tissue Culture Techniques | 2 | 2025 | 81 | 0.370 |
Why?
|
| Coculture Techniques | 2 | 2025 | 172 | 0.360 |
Why?
|
| Cell Communication | 2 | 2025 | 221 | 0.350 |
Why?
|
| Nanofibers | 3 | 2017 | 32 | 0.340 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 489 | 0.340 |
Why?
|
| Antigens | 2 | 2023 | 231 | 0.340 |
Why?
|
| Adaptive Immunity | 2 | 2023 | 181 | 0.330 |
Why?
|
| Immune System | 2 | 2022 | 103 | 0.330 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 1192 | 0.320 |
Why?
|
| Models, Theoretical | 1 | 2012 | 503 | 0.300 |
Why?
|
| Thrombin | 2 | 2009 | 61 | 0.300 |
Why?
|
| Adjuvants, Immunologic | 2 | 2024 | 174 | 0.290 |
Why?
|
| Blood Coagulation Tests | 1 | 2008 | 32 | 0.280 |
Why?
|
| Biological Transport | 2 | 2020 | 412 | 0.280 |
Why?
|
| Peptides | 3 | 2017 | 671 | 0.270 |
Why?
|
| Microscopy, Fluorescence | 2 | 2018 | 443 | 0.250 |
Why?
|
| T-Lymphocytes | 3 | 2024 | 1310 | 0.230 |
Why?
|
| Intervertebral Disc | 1 | 2025 | 30 | 0.230 |
Why?
|
| Surface Properties | 2 | 2018 | 131 | 0.230 |
Why?
|
| Photochemical Processes | 1 | 2024 | 15 | 0.220 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 2386 | 0.220 |
Why?
|
| Cross-Linking Reagents | 1 | 2024 | 91 | 0.220 |
Why?
|
| Intervertebral Disc Degeneration | 1 | 2025 | 63 | 0.220 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2024 | 325 | 0.200 |
Why?
|
| Polyethylene Glycols | 1 | 2024 | 376 | 0.190 |
Why?
|
| Rotation | 1 | 2022 | 94 | 0.180 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2022 | 84 | 0.180 |
Why?
|
| Macrophages | 2 | 2025 | 623 | 0.180 |
Why?
|
| Models, Biological | 4 | 2022 | 1809 | 0.180 |
Why?
|
| Stress, Mechanical | 1 | 2022 | 261 | 0.170 |
Why?
|
| Tissue Array Analysis | 1 | 2021 | 132 | 0.170 |
Why?
|
| Biophysics | 1 | 2021 | 157 | 0.170 |
Why?
|
| Humans | 11 | 2023 | 95795 | 0.170 |
Why?
|
| Ninhydrin | 1 | 2020 | 1 | 0.170 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2020 | 12 | 0.160 |
Why?
|
| Cell Tracking | 1 | 2020 | 14 | 0.160 |
Why?
|
| Thymus Gland | 1 | 2021 | 206 | 0.160 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2020 | 85 | 0.160 |
Why?
|
| Computer Simulation | 2 | 2023 | 1158 | 0.160 |
Why?
|
| Microscopy, Confocal | 1 | 2020 | 286 | 0.160 |
Why?
|
| Oxygen | 1 | 2024 | 781 | 0.150 |
Why?
|
| Antibody Affinity | 1 | 2019 | 38 | 0.150 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2019 | 87 | 0.140 |
Why?
|
| Female | 6 | 2024 | 49870 | 0.140 |
Why?
|
| Nanoparticles | 1 | 2020 | 197 | 0.140 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 2882 | 0.140 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2019 | 509 | 0.140 |
Why?
|
| Vaccines, Subunit | 2 | 2017 | 55 | 0.130 |
Why?
|
| Immunity, Innate | 1 | 2021 | 464 | 0.130 |
Why?
|
| Antibody Formation | 2 | 2017 | 181 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 1124 | 0.120 |
Why?
|
| Tuberculosis Vaccines | 1 | 2015 | 19 | 0.120 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 547 | 0.120 |
Why?
|
| Perfusion | 1 | 2016 | 266 | 0.110 |
Why?
|
| Cell Movement | 1 | 2019 | 816 | 0.110 |
Why?
|
| Antigens, Bacterial | 1 | 2015 | 138 | 0.110 |
Why?
|
| Neoplasms | 2 | 2022 | 3240 | 0.110 |
Why?
|
| Cells, Cultured | 1 | 2020 | 2929 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 712 | 0.100 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2015 | 208 | 0.100 |
Why?
|
| Vaccines | 1 | 2014 | 84 | 0.100 |
Why?
|
| Viscosity | 1 | 2012 | 51 | 0.090 |
Why?
|
| Nuclear Energy | 1 | 2011 | 2 | 0.090 |
Why?
|
| Chemical Fractionation | 1 | 2011 | 6 | 0.090 |
Why?
|
| Radiochemistry | 1 | 2011 | 5 | 0.090 |
Why?
|
| Biomarkers | 1 | 2018 | 1931 | 0.090 |
Why?
|
| Lanthanoid Series Elements | 1 | 2011 | 12 | 0.090 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 102 | 0.090 |
Why?
|
| Solvents | 1 | 2011 | 90 | 0.090 |
Why?
|
| Staphylococcus aureus | 1 | 2014 | 285 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 2383 | 0.080 |
Why?
|
| Bacterial Proteins | 1 | 2015 | 922 | 0.080 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2008 | 43 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 930 | 0.070 |
Why?
|
| Bacterial Infections | 1 | 2008 | 183 | 0.060 |
Why?
|
| Annulus Fibrosus | 1 | 2025 | 6 | 0.060 |
Why?
|
| Nucleus Pulposus | 1 | 2025 | 6 | 0.060 |
Why?
|
| Valinomycin | 1 | 2005 | 8 | 0.060 |
Why?
|
| Epitopes | 2 | 2017 | 258 | 0.060 |
Why?
|
| Lipid Bilayers | 1 | 2005 | 147 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2025 | 255 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 2039 | 0.050 |
Why?
|
| Cell Survival | 1 | 2025 | 1029 | 0.050 |
Why?
|
| Kinetics | 3 | 2011 | 1561 | 0.050 |
Why?
|
| Drug Liberation | 1 | 2022 | 18 | 0.050 |
Why?
|
| Male | 2 | 2025 | 45684 | 0.040 |
Why?
|
| Chemical Precipitation | 1 | 2020 | 18 | 0.040 |
Why?
|
| Inflammation | 2 | 2017 | 1063 | 0.040 |
Why?
|
| Bacillus cereus | 2 | 2009 | 10 | 0.040 |
Why?
|
| Sex Factors | 1 | 2022 | 1127 | 0.040 |
Why?
|
| Immunotherapy, Active | 1 | 2017 | 15 | 0.030 |
Why?
|
| Bacterial Vaccines | 1 | 2017 | 45 | 0.030 |
Why?
|
| Particle Size | 1 | 2017 | 126 | 0.030 |
Why?
|
| Age Factors | 1 | 2022 | 1957 | 0.030 |
Why?
|
| Listeriosis | 1 | 2017 | 90 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2017 | 118 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2017 | 305 | 0.030 |
Why?
|
| Alum Compounds | 1 | 2013 | 5 | 0.030 |
Why?
|
| B7-2 Antigen | 1 | 2013 | 42 | 0.030 |
Why?
|
| B7-1 Antigen | 1 | 2013 | 75 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2013 | 93 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2013 | 151 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2013 | 201 | 0.020 |
Why?
|
| Actinoid Series Elements | 1 | 2011 | 1 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2011 | 37 | 0.020 |
Why?
|
| Phosphorus | 1 | 2011 | 119 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 1425 | 0.020 |
Why?
|
| Thromboplastin | 1 | 2009 | 9 | 0.020 |
Why?
|
| Enzyme Precursors | 1 | 2009 | 20 | 0.020 |
Why?
|
| Plasma | 1 | 2009 | 51 | 0.020 |
Why?
|
| Water | 1 | 2011 | 307 | 0.020 |
Why?
|
| Fluorescence | 1 | 2009 | 104 | 0.020 |
Why?
|
| Factor X | 1 | 2008 | 3 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2013 | 541 | 0.020 |
Why?
|
| Prothrombin | 1 | 2008 | 19 | 0.020 |
Why?
|
| Metalloproteases | 1 | 2008 | 10 | 0.020 |
Why?
|
| Quorum Sensing | 1 | 2008 | 28 | 0.020 |
Why?
|
| Linear Models | 1 | 2009 | 438 | 0.020 |
Why?
|
| Bacillus anthracis | 1 | 2008 | 74 | 0.020 |
Why?
|
| Environment | 1 | 2009 | 231 | 0.020 |
Why?
|
| Rosaniline Dyes | 1 | 2005 | 9 | 0.010 |
Why?
|
| Ion Transport | 1 | 2005 | 87 | 0.010 |
Why?
|
| Liposomes | 1 | 2005 | 99 | 0.010 |
Why?
|
| Algorithms | 1 | 2009 | 2015 | 0.010 |
Why?
|